Catalyst Pharmaceuticals (CPRX) Other financing activities (2013 - 2026)

Catalyst Pharmaceuticals' Other financing activities history runs 13 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• Quarterly Other financing activities fell 31.02% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (down 21.42% YoY) and the FY2025 annual result came in at $14.7 million, up 8.54% from the prior year.
• Other financing activities was $3.3 million for Q1 2026 at Catalyst Pharmaceuticals, up from $1.9 million in the prior quarter.
• Across five years, Other financing activities topped out at $6.0 million in Q4 2024 and bottomed at $200000.0 in Q3 2023.
• A 5-year average of $2.6 million and a median of $2.0 million in 2024 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2023 — Other financing activities sank 95.0% — and 2024, when it jumped 1900.0%.
• Catalyst Pharmaceuticals' Other financing activities stood at $3.2 million in 2022, then tumbled by 78.35% to $693000.0 in 2023, then surged by 763.49% to $6.0 million in 2024, then sank by 68.65% to $1.9 million in 2025, then soared by 76.01% to $3.3 million in 2026.
• Business Quant data shows CPRX's Other financing activities at $3.3 million in Q1 2026, $1.9 million in Q4 2025, and $5.8 million in Q3 2025.